Second-line rescue treatment of infection: Where are we now? - Wikidata - wikimedia - TriplyDB

Second-line rescue treatment of infection: Where are we now?

Second-line rescue treatment of infection: Where are we now?

http://www.wikidata.org/entity/Q58602176

about

Second-line rescue treatment of infection: Where are we now?

http://www.wikidata.org/entity/Q58602176

description

im Oktober 2018 veröffentlichter wissenschaftlicher Artikel

@de

wetenschappelijk artikel

@nl

наукова стаття, опублікована в жовтні 2018

@uk

name

Second-line rescue treatment of infection: Where are we now?

@en

Second-line rescue treatment of infection: Where are we now?

@nl

type

label

Second-line rescue treatment of infection: Where are we now?

@en

Second-line rescue treatment of infection: Where are we now?

@nl

prefLabel

Second-line rescue treatment of infection: Where are we now?

@en

Second-line rescue treatment of infection: Where are we now?

@nl

P1433

Q58602176-BA87C37C-F7BD-4D73-B679-64386BAB973E

P1476

Q58602176-751D228A-F167-4104-B1A3-1C680776E43C

P2093

Q58602176-405E8F8F-9D34-4A82-B068-EE3E33E9DDAE

Q58602176-6A38E72C-4239-41EA-B0F4-E8D9ED5C8FE5

P275

Q58602176-384DD7B3-2E8C-4890-8F60-D4F4A1253F0D

P2860

Q58602176-05D01E45-25EE-4FB9-BF7F-5D0044288906

Q58602176-06782F29-4FD5-45FF-B5EB-9F744011D43B

Q58602176-07F3AAA1-63C8-426C-8909-5C2BB43164F2

Q58602176-1BE17E06-7DEF-43A2-B44E-25296DEAEEEA

Q58602176-24FB5522-4772-4430-8943-473FCD2C032C

Q58602176-29C766B3-3BAB-47C8-A887-DD66561AE4F5

Q58602176-2B3AF909-618C-4EAE-8D0B-FAFFD9C44161

Q58602176-2C601583-3E7D-4090-B279-C67D9F9E1489

Q58602176-31A63BCC-B664-418C-ADF4-265F17B6899A

Q58602176-380ECC02-4249-481E-BF0A-4DF03EE5E433

P304

Q58602176-79DB7F9D-D171-4BD2-834A-3741501A4E7A

P31

Q58602176-7B50600C-5E23-40A6-89A1-3F3055CD8E3E

Q58602176-F2E9C630-EE99-4D3E-9CA9-3C4398AAA878

P356

Q58602176-64878714-918A-420C-A9FC-1E20183D388C

P407

Q58602176-AA007E62-F122-408F-B7FF-DCA4973029A3

P433

Q58602176-D232F7C7-9176-4FD0-9FD6-2BC0735F3072

P478

Q58602176-3C52498C-4A1B-462A-92D7-B2A6294CC68A

P5008

Q58602176-0D6F4DA8-B82F-4152-B7A8-83222E512F2D

P577

Q58602176-13EE56AD-242D-4C46-B2B5-8CEE52FE407F

P698

Q58602176-D8F0746D-F3D4-4C77-91D1-05B4D8F849B6

P921

Q58602176-1B53269D-A9C5-4176-999B-79D02A70EF63

Q58602176-569F39BF-F183-490B-997D-0C3A9E3E4325

Q58602176-6EAD0816-5FEA-4F18-8785-38EC0506A6DF

Q58602176-FC00715F-FDD3-431C-AFC5-6C4223391BF1

P932

Q58602176-DA608486-32BD-45A7-AE40-9D020B48E78C

P356

WJG.V24.I40.4548

P1433

World Journal of Gastroenterology

P1476

Second-line rescue treatment of infection: Where are we now?

@en

P2093

Ping-I Hsu

http://www.w3.org/2001/XMLSchema#string

Te-Fu Lin

http://www.w3.org/2001/XMLSchema#string

P275

Creative Commons Attribution-NonCommercial 4.0 License

P2860

The problem of Helicobacter pylori resistance to antibiotics: a systematic review in Latin America

Prevention of nitroimidazole resistance in Campylobacter pylori by coadministration of colloidal bismuth subcitrate: clinical and in vitro studies.

Helicobacter pylori uptake and efflux: basis for intrinsic susceptibility to antibiotics in vitro

Modified sequential Helicobacter pylori therapy: proton pump inhibitor and amoxicillin for 14 days with clarithromycin and metronidazole added as a quadruple (hybrid) therapy for the final 7 days.

Management of Helicobacter pylori infection-the Maastricht V/Florence Consensus Report.

A new look at anti-Helicobacter pylori therapy

High-dose dual therapy is superior to standard first-line or rescue therapy for Helicobacter pylori infection

7-Day Nonbismuth-Containing Concomitant Therapy Achieves a High Eradication Rate for Helicobacter pylori in Taiwan.

Changing antimicrobial susceptibility epidemiology of Helicobacter pylori strains in Japan between 2002 and 2005.

Levofloxacin/amoxicillin-based schemes vs quadruple therapy for Helicobacter pylori eradication in second-line.

P304

4548-4553

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.3748/WJG.V24.I40.4548

http://www.w3.org/2001/XMLSchema#string

P407

P433

40

http://www.w3.org/2001/XMLSchema#string

P478

24

http://www.w3.org/2001/XMLSchema#string

P5008

P577

2018-10-28T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

30386104

http://www.w3.org/2001/XMLSchema#string

P921

gastroenterology

mechanism of action

Helicobacter pylori infectious disease

P932

6209570

http://www.w3.org/2001/XMLSchema#string